Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
January $5s Options are blowing UP!!!!! .75/1.00
Damn Right P'Xena! Topping action in $6s and settle +$5.50. You go girl you had it all along!
Assault on the 50 week VWAP at $5.00. Missling has the Biogen fuel to burn the shorts, they will cover enmass today and likely go LONG!
I took it to mean the Rett's and Fragile X will come first. Any thoughts anyone?
Listen again you missed the point. Rett's and fragile X come first. They will be fulling funded outside of AVXL. We will continue ALZ trial under different dosage with those already ENTHUSIALIASTICLY ENROLLODED. Avxl does not pay Aussie Govt. and others pay. NO DEBT!!! Will not issues new shares for capital!!!! What the hell look at SEC filings AVXL will not pay it is happening organically.
NO DEBT!!! Will not raise MONEY!!! 2 trials will start soon!!
FDA says side effects prove Blood brain penetration!! so mild side effects are a positive!!!!!!!!!!
RETT and Infantile comes NOW!!
Tau is reduced! Inflammation reduced! Not beta Tau need fire truck!! A2-73
Missing is a smart guy !!! fire truck!! We have fire truck!! AVXL is no one's BITCH!!
NEW PARADIGM!!!
Missing speaking now!!! go to Anavex.com and listen from link
slides are up presentation beginning now
Potential short attack ALERT!!! 1:44 PM EST. Slides will be shown here: http://wsw.com/webcast/ladenburg2/avxl/index.aspx 15 minutes before the presentation at 2 PM EST naturally the short attack will be timed to those slides but the greedy are always quick to cut the throat. So one would expect for the short attack to be underway before the slides are released. We will need out best traders here to support the action. I canceled my big stinkers I had set (real bids) @$3.01 which the MM danced around. Do one's best to support a bottom IF there is a SHORT ATTACK like I said I liked $3.01 but I will wait to see we have 123Tom and other's support steps to consider. I like the $2.80 I will strike there and again at $2.60 if it comes to that.
A "White Knight Calvary" (Tutes and Insty's) should show up at some point but likely will not be until after the short attack (IF THERE IS ONE) has reached the maximum penetration in depth from the LINE @ $3.01
GOOD LUCK and Please Support YOUR COMPANY today.
Todays Spoof asks were Obscene! What a flagrant display of contempt and arrogance basically criminals telling everyone they own the Street and therefore the SEC. 100K share spoof asks at 3.02 and again at 3.03 with bids of 20K shares at a penny less and they do not trade, if someone wanted to sell so much so badly surely they would have taken the big bid, they did not. Why???? Because the bid and ask are of the same firm or design. Froll, you are flat wrong at least in this stock today ( and on many days in the past) this was not a market. It was a shell game, a trap, a manipulated (legally no doubt since Market Makers have the "Madoff" rule so graciously bestowed on the former darling of the SEC and therefore named after him when he was highly respected.)
The last three candles spell DANGER/OPPORTUNITY (CRISIS) Fridays bad candle now has a doji Harami, anfter the bearish belt hold candle. These three can be seen as an ACUTE wedge formation together with constriction of the Bollinger Bands could mean a BIG break from the pinnacle of the wedge. (Mondays close.) If we will get your swing action, they have measured and taped it out today it might get violent Today Tuesday 9/27/16. BTW anyone with a margin account has 3 day trades in a 5 day rolling period. This likely will get lively Tuesday and I do not trust my read or the other market participants.
Good Luck and (MOSTLY I ACCUMULATE)
OK, Eagle8, no worries brother. I did not mean to pick on you I am just tired of people that are not invested in this company howling around about irrelevant factors. The plan is to have the trials paid for by partnerships and grants. So far most of the trials have been paid for by grants and outside sources doing research. Anavex uses it's money wisely and frugally to avoid debt and secondary securities sales. So no debt or securities sold will be sold to finance these trials. That has been the plan and it is the plan going forward. This is great benefit to us as shareholders. One does not have to be an accountant to recognize that Anavex has an excellent balance sheet for a clinical stage company.
Good Luck
Sorry but it seems everyone one this board both long term shareholders and others with no position do not have a clue about the financial structure and funding capabilities of THIS DEBT FREE COMPANY? Get it? As a shareholder you owe nothing! There are no bond holders superior to your interest. Management basically gets Govts. and Foundations to GIVE them (you as shareholder) money for research. Whatever it costs if you are not paying then it sounds like bashing to yap on about it.
It was directly funded by Australian Government to the Australian providers none went to Anavex and Australia paid none of Anavex admin. expenses. Somewhat similar to how NIH health studies are done in the USA, NIH funds the studies by payments to the hospitals and Universities not to the company. All of this information is in the SEC filings which of course I know you know how to access so no need to provide a link to you. I do not expect you to be cognizant of the SEC filings and detailed background of this company as you are admittedly just a "casual observer"
Agreed then LET ME REPEAT! Cost will be close to ZERO! I will not be lead astray by what you say is innocent question. It is irrelevant as the COMPANY will not pay the cost. If you have been a shareholder so long you should realize how these trials are funded. It is not from DEBT or DILUTION it will be by Govt., Foundation Grants or Partnership. PERIOD! That is how it has been and this is how it will be going forward. Everything else is a short thesis fantasy. So again let me repeat! Do not scratch at phantom limbs!
I appreciate your sentiment but it means nothing to Anavex. Another A-beta antibody drug. AXON took a big hit yesterday with the other failure of this worn out line of research. A2-73 is totally different. It has a gentle formula that works with ones own system to bring it in balance. So one would think a big ass BP that loves this slogan might like Anavex. (Bristol Meyers Squib Ha Ha!)
It will cost you as a shareholder ZERO! Missling has a brilliant and overarching plan of the development of this company which is ZERO Debt and ZERO Dilution. The science is compelling Aussie Govt. paid most of the ALZ trials expenses so far. This method will continue as a shareholder you should be patient and grateful that management is so frugal. All of this is risky business however Missling is not making the shareholders pay, when the company gets these expenses paid by third parties it goes directly to benefit the shareholders of a DEBT FREE COMPANY!!!! Quit scratching phantom limbs; money is of no issue, there is no debt to service, there will be no dilution to pay for trials. Trials will be paid for by partnerships or grants, PERIOD! If the science does not support the trials whereby third parties do not support Anavex then they will not be done. Anavex will not issue debt for these trials, the science is compelling. Researchers and Universities all over the world are cautiously getting on board. This is an extremely early stage company and it is extremely risky AND the universe shone a light on you for even knowing it exists. One should in every adventure or misadventure ask themselves "Why did I come to the Planet" and "How can I benefit my fellow humans struggling on the planet." It takes extreme courage to face Parkinson's; Ali and my Mother fought with cheerfulness and courage in the face of increasing debilitation. Michael will FIGHT! More for others than for himself but one can be sure he will fight with every ounce of courage God grants him.
Take your next vacation in beautiful Australia as an AVXL shareholder you owe them.
I agree and my Mom fought courageously against Parkinson's. Thank "Turd Boy" for the chance to reload this morning and then just flush him. He is not worthy of the ignited gasoline we have been loading for the rest of the shorts.
Coverage by this Investment Bank/Advisor firm would be a huge win they are solid second tier and specialist to some extent in biotech.
Vomitus of "Vampires of the Short Cabal"? Surely it it will come. Of course those adherents of "efficient market" theory will dismiss drop as just "normal" market forces.
AF and Jean F in Dallas have to tweet at least please anyone tuned in to that please report.
I suspect a multi-day run, because I am light on my load of shares (never fails! haha) Not to worry I will buy it back higher because I only sell for defense. YOU HEARD IT HERE FIRST THREE DAY GAPER, (because I am chasing now)
"The Pearls of Inestimable Value" lie within potential to accelerate change to the positive. A paradigm shift was accepted in geology recently(in science terms of time) and is now Dogma. There was less resistance in the realms of Privilege, Property and Law. Of these "privileged and protected institutionally ingrained" there is a natural (for those interests so previously privileged) to push back on those that threaten their realm.
That said one can examine the tide of Cannabis Medical and Recreational, the rise of organic food and natural healing to understand that the "Assassination Generation" and their children and grand-children will not stand for denial of beneficial health alternatives. We know or should know that Big Food shove toxins down our throats and Big Govt bought and paid supports them.
Case in Point: Searle, Rumsfeldt and Nutrasweet.
Un fing beleivable ! Gilead was saved by the saving grace of the science but Donald Rumsfeldt went on to be the big bully of the Bush Jr. ill fated and geopolitically devastating "War on Terror"
Everything is connected. These our our people! This is OUR PLANET!!
All Longs Need to "Grow a Pair!" Stand up to the weak and decadent rat faced "Vampires of the Short Cabal!" (Has one seen a picture of the face of Skrelli or Fuernestien?)This post should remind us why we are here. There MIGHT be a small molecule (or two) that MIGHT be in due time considered "Pearls of Inestimable Value!"
(I can say grow a pair because one of the WOMEN said it first; lately they are the ones with the cajones!)
That was So Cool! Thank you!
Might a presentation at such a conference result in coverage by a Ladenburg Thalmann analyst? This is an investment advisor firm and also a second tier Investment Banking firm with some emphasis on Biotechnology. Same as the Japanese firm from this week, which is much bigger globally but Ladenburg Thalmann is well known in USA circles. One two punch anyone? How about a "Three Gaps Up" technical setup?
When the volume is as was today MM and even the vaunted organized "Vampires of the Short Cabal" real or imagined have lost all control. I follow your TA and it has proven eerily prescient in the past. I have always just bought and held accumulating more on the down turns.
Too many times I held in a 20-30% gain day to see it erased, mainly out of fear I would miss the "moonshot" run. Equation has been solved. Fear no more. I am not a trader I am a long term buy and hold FA guy. But now I trade for defensive purposes. When I do trade I am sometimes get caught chasing as in the "THREE GAPS UP" starting June 28, 2016. As I say I usually just keep buying more every month no matter the price but having been rag dolled around thought I should trade it late June. I got left in the dust ALMOST as the thoroughbred Anavex was running I jumped on quarter horses Threshold, Galena and Regulus to give chase. I paid up for Anavex when she paused a few days later, then she ran again.
This time I bought back a considerable amount at end of the day but still light about 50%. Good news for fellow longs is I will fashion it into 5,000 and 10,000 broker assisted VWAP Wall bunker busters ask slap bombs to counter the crappy spoof asks of the "Vampires of the Short Cabal" (real or imagined ha ha) I do not care if I lose a little pennies on the trade. I pay up and I pay down. In the end it MAY not take a large position to satisfy one real needs and held for a very long time MIGHT build generational wealth.
Now, I do not fear any move I will sell the pops to soon and buy the drops to soon. I am in for the long haul and if one is patient and persistent
one should be content to let one's account to build with the development of the company.
That said look for the three gaps up just for the fact I am light my AVXL position. "The World Eats Jimmy"
Good Luck
Where do you think the price of that stock would have gone had it met it primary end point of it's Ph2b clinical trial instead of "failed". A2-73 has met all it's designed end points so far.
Your point is???
38 week data will not delay the clinical progress of A2-73 unless people start getting sick or dying from the drug. I do not see that happening. If this is a "dead" stock why are you here constantly kicking it? Is it not time for you to move along?
Yes Tobira had a very successful IPO in June 2014. The stock closed that week at $25. It closed yesterday at $38more than 50% higher than IPO week and 775% higher than then Monday. Your point?
I follow your charting closely that is why I wanted you to be aware of the premarket action which another poster here observed as well. Any possible reason I proposed was purely supposition but what was important was it was pre-market spike which I assume can be used as a manipulative bull trap as well, trapping momo traders "thinking something is up."
What I thought it might have shown is that the resistance ceiling is weak and a real catalyst could propel the stock in a sustained 10% or better spike. I saw my account go way up but did not give a second thought about trying to trade it. What we got was what I was hoping for $0.03. A steady holding this base with small gains might build confidence in the Investors that are not big hot money traders to add to or build positions here. That could help the stock build a strong base or floor going forward.
My charting is not as advanced as yours I mostly look at Japanese Candle patterns, Fridays Harami Doji reversal pattern was confirmed by Mondays engulfing Marubozu. Today's candle I will discount and ignore. (ugly as it is!) If we can hold today's low and maybe get an increase I will feel more confident that a reversal MIGHT be in the works here.
Good Luck and keep up the good work. I assure you, the thoughtful and open minded do pay heed.
It seems in that "market" perception/mis-perception of clinical trial results can present a compelling investment opportunity. Case in point; Tobira Therapeutics. Phase 2b did not meet primary end point stock fell from $11 to sub $4 gapping down stating Aug 25 then less than a month later bought out by Allergan, whose scientist's presumably understand, for $1.7 Billion and price spikes to $38 in one day. Yes, NASH drugs are a big focus now but do not have the breath and depth of CNS pipelines. Then, of course, so many are quick to dismiss the Allergan/Heptares $3 Bil licensing deal.
One needs to ask one's selves, is this a good time to accumulate AVXL?
I would like to agree with that, and it would be nice to get that first test of an overhead resistance. But today's CANDLE MIGHT have been an anomaly and one MIGHT want to discount it and ignore it for technical charting. I watched, it was occasioned by a big pre-market buy which spiked the price. Could be any number of reasons but TBRA another baby bio was spiking pre-market 500%. AVXL spike looked like a 77,000 share market buy order, pre-market. So might have been just a quick short covering of a profitable short position in AVXL to free up capital to cover a short TBRA position before it got out of hand.
Good news for us FUNDIE INVESTORS is that merger/acquisition season is in full swing. Allergan is going on a tear, first Heptares $3Bil License deal now buyout of $34 Million Market cap Tobira Therapeutics for $1.7 Bill ( Lead drug is NASH Drug only in PH 2b)
$5 Bill for AVXL when they show promise in Phase 2b/3?
One never knows in the crazy world of Biotech Frenzy.
GLTA!
Go Anavex Life Sciences!
Of course I am not comparing the Heptares M1 receptor drug to Anavex A2-73. A2-73 involves Sigma-1 receptor but concomitantly the Muscarinic receptors, A2-73 is much more advanced clinically AND has great interest from the independent scientific community at various research Universities and research institutions and is being studied for a wide range of medical disorders both CNS related and otherwise. There is excitement in the scientific community regarding the sigma-1 receptor aspect.
You are right $3 billion is not nearly enough for the licensing of A2-73.
Or maybe you have good deductive reasoning skills.
Connect the dots! We shall soon see.
It is darkest before the dawn sort of thing, Mr. "Rising Sun"
The daily chart candles showing Harami Doji pattern the last two days also bode well for a technical reversal as well as the time and sales patterns today, with the repeated multi K ask slaps and the 10K block trade ask slap at 9.37 am @ $2.49 (one penny below open) to get the ball rolling. This pattern at the end of a three day slide MIGHT indicate a possible reversal in the purely technical trading patterns. Daily Chart shows RSI at 26! Chart technical indications show AVXL due for a bounce. Does not mean it will happen but increases the odds. One might be surprised at the force and rapidity a technical bounce could have at these levels.
A TA bounce MIGHT be further fueled by fundamental catalysts in the coming days and weeks with a possible one two punch next week.
Go Anavex Life Sciences!
The Allergan/Heptares $3bil licensing deal for a PH1 ALZ drug must have completely stupefied you if that is your belief.
A partnership with a Japanese Firm would likely include taking an equity/stock position in the AVXL to make it partly a Japanese Company. $100Mil Shelf has been perfected, deemed effective by SEC and Prospectus issued under the guise of the Lincoln deal. The price paid by the Japanese firm will set a floor under the stock price, get AVXL must needed funding AND further allow AVXL to put shares to Lincoln at a favorable price if and when needed.
Connect the dots.
Can Missling play Chess?
GLTA Longs and Believers!
Go Anavex Life Sciences!
AVXl's Patent Attorney was Takeda's Patent Attorney in the past. Short Lines of TRUST! Takeda can have confidence in AVXL's Patents and Intellectual Properties because of this relationship. As Xena stated it would be consistent with Japanese Business culture to have any Partnership agreement announced at an Investors conference dominated by Japanese Firms.